Rat superior cervical ganglion (SCG) neurons express lowthreshold noninactivating M-type potassium channels (I K(M) ), which can be inhibited by activation of M1 muscarinic receptors. This inhibition occurs via pertussis toxin-insensitive G-proteins belonging to the G␣ q family (Caulfield et al., 1994) . We have used DNA plasmids encoding antisense sequences against the 3Ј untranslated regions of G␣ subunits (antisense plasmids) to investigate the specific G-protein subunits involved in muscarinic inhibition of I K(M) . These antisense plasmids specifically reduced levels of the target G-protein 48 hr after intranuclear injection. In cells depleted of G␣ q , muscarinic inhibition of I K(M) was attenuated compared both with uninjected neurons and with neurons injected with an inappropriate G␣ oA antisense plasmid. In contrast, depletion of G␣ 11 protein did not alter I K(M) inhibition. To determine whether the ␣ or ␤␥ subunits of the G-protein mediated this inhibition, we have overexpressed the C terminus of ␤ adrenergic receptor kinase 1 (␤ARK1), which binds free ␤␥ subunits. ␤ARK1 did not reduce muscarinic inhibition of I K(M) at a concentration of plasmid that can reduce ␤␥-mediated inhibition of calcium current (Delmas et al., 1998a) . Also, expression of ␤ 1 ␥ 2 dimers did not alter the I K(M) density in SCG neurons. In contrast, I K(M) was virtually abolished in cells expressing GTPase-deficient, constitutively active forms of G␣ q and G␣ 11 . These data suggest that G␣ q is the principal mediator of muscarinic I K(M) inhibition in rat SCG neurons and that this more likely results from an effect of the ␣ subunit than the ␤␥ subunits of the G q heterotrimer.
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The M-type potassium current (I K(M) ) is a noninactivating, voltage-gated potassium current found in various peripheral and central neurons, including rat superior cervical ganglion (SCG) neurons, and in some cell lines (for review, see Brown, 1988) . It is activated in the subthreshold voltage range for action potentials and increases with membrane depolarization. Thus, cells remain clamped around rest, display spike adaptation, and have limited excitability. Inhibition of I K(M) results in depolarization with increased action potential discharge (Brown and Selyanko, 1985) and provides a switch between phasic and tonic firing properties (Wang and McK innon, 1995) . I K(M) in rat SCG neurons can be inhibited after activation of various receptors, including M 1 muscarinic receptors [M 1 mAChR Bernheim et al., 1992) ] and bradykinin B 2 receptors , coupled through Bordetella pertussis toxin-insensitive GTPbinding proteins (G-proteins) Caulfield et al., 1994; Jones et al., 1995) .
Using antibodies raised against the C-terminal domain of different G␣ subunits, we have previously obtained evidence to suggest that the G-protein ␣ subunits involved in M 1 mAChRmediated inhibition of I K(M) in rat SCG neurons include G␣ q or G␣ 11 or both (Caulfield et al., 1994) . However, the antibodies that were used could not distinguish between G q and G 11 because they have identical C-terminal sequences (Strathmann and Simon, 1990) . Because the C terminus is thought to be a locus of G-protein GDP-bound ␣ subunit/receptor and GTP-bound ␣ subunit/phospholipase C-␤1 (PLC-␤1) interactions Arkinstall et al., 1995) , G␣ q and G␣ 11 can couple to the same receptors (Aragay et al., 1992; Wu et al., 1992b; Nakamura et al., 1995; Dippel et al., 1996) , and the cloned subunits stimulate the different PLC-␤ isoforms to a similar degree (Taylor et al., 1991; Hepler et al., 1993; Jhon et al., 1993) . However, they are not invariably equivalent, because in rat portal vein myocytes, G␣ q and G␣ 11 elevate intracellular calcium levels after ␣ 1 -adrenoceptor activation by coupling to very different mechanisms (Macrez-Leprêtre et al., 1997) .
In the present experiments, we have therefore tried to find out whether either or both of these two G-proteins (G q and G 11 ) were involved in muscarinic inhibition of I K(M) in rat SCG neurons by using G␣ antisense-generating plasmids to deplete cells of specific subunits. We have also sought evidence to determine whether the ␣ subunit or the ␤␥ dimer of the activated dissociated heterotrimer acted as the primary intermediary (Wickman and Clapham, 1995; C lapham and Neer, 1997) by selectively overexpressing ␤␥ subunits or GTPase-deficient forms of the ␣ subunits and by testing whether a ␤␥-sequestering agent [C -terminal peptide of ␤ adrenergic receptor kinase 1 (␤ARK1)] modified the effect of mAChR stimulation.
Our results suggest that G␣ q , but not G␣ 11 , couples the M1 mAChR to I K(M) inhibition in SCG neurons and that ␣, rather than ␤␥, subunits are the mediators of this response.
MATERIALS AND METHODS
Cell culture. Sympathetic neurons were isolated from SCG of 15-to 19-d-old Sprague Dawley rats and cultured using standard procedures as described previously (Delmas et al., 1998a) . DNA plasmids. The constructs used in this study were made by PCRcloning using standard molecular techniques (Abogadie et al., 1997) . These were designed antisense to sequences in the 3Ј untranslated (3ЈUT) regions of the rat target genes and subcloned into pCR3 or pCR3.1 (Invitrogen, San Diego, CA) unless stated otherwise. The cloned 3ЈUT sequences share no significant homology with any other rat G-protein ␣ subunits. The nucleotide sequences reported in this paper have been submitted to the GenBank / EM BL Data Bank with accession numbers Y17161, Y17162, Y17163, and Y17164. The clones are as follows, in 5Ј to 3Ј orientation [nucleotide (nt); coding region (CR); numbers indicate position relative to stop or start codon]: G␣ oA (clone 207-8) 3ЈUT nt 2-169 : C TC TTGTCC TGTATAGCAACC TATTTGA-C TGC TTCATGGAC TC TTTGC TGTTGATGTTGATC TCC TGGTA-GCATGACC TTTGGCC TTTGTAAGACACACAGCC TTTC TGTAC -CAAGCCCC TGTC TAACC TACGACCCCAGAGTGAC TGACGGC-TGTGTATTTC TGTA; G␣ : ATGAC TTGGACCGTGT-AGCCGACCC TTCC TATC TGCC TACACAACAAGATGTGCTTAG-AGTTCGAGTCCCCACCACAGGGATCATTGAGTACCCC TTCGA-C TTACAGAGTGTCATC TTCAGAATGGTCGATGTAGGAGGCCA-AAGGTCAG-AGAGAAGAAAATGGATACACTGCTTTGAAAACG-TCACCTCGATCATGTTTCTGGTAGCGCTTAGCGAATACGATCA-AGTTCT-TGTGGAGTCAGACAATGAGAACCGCA; G␣ 11 antisense clones: 243-7, 3ЈUT nt 4 -104; C97-4, 3ЈUT nt 82-123. G␣ q antisense clones: C23-24, 3ЈUT nt 6 -289; C6 -6, 3ЈUT nt 6 -129; C23-D7, . Targeted sequences are shown in Figure 1 .
The constitutively active, GTPase-deficient form of hamster G␣ q (Q209L) (Wu et al., 1992a) was subcloned into the pC M V5 vector, the GTPase-deficient G␣ 11 (Q209L, also known as 11QL) (Wu et al., 1992a ; from S. Offermanns) was provided in the pCIS vector, and the GTPasedeficient G␣ oA (Q205L) (Wong et al., 1992 ; from B. R. Conklin) was provided in the pCDNA1 vector. Bovine ␤ 1 and ␥ 2 subunits were subcloned into pCDNA3 (Invitrogen). The C -terminal Gly495 to Leu689 of human ␤ARK1 (also called GRK2) (Koch et al., 1994 ; from C. Scorer and C. Harris) was supplied in the vector pCI N1 engineered with new NotI and EcoRI sites. All plasmids were propagated in either X L -1 blue or DH5␣ Escherichia coli and purified using maxiprep columns (Qiagen, Hilden, Germany). All clones were verified by sequencing. RNA synthesis was driven by a strong viral promoter (cytomegalovirus) to ensure sustained high intracellular levels of transcripts after delivery of plasmids.
In situ hybridization. In situ hybridization was performed on 12 m cryostat sections of 17-d-old rat SCGs using digoxigenin-labeled riboprobes, essentially as described previously (Schaeren-Wiemers and Gerfin-Moser, 1993) . Sense and antisense cRNAs were transcribed from the same clones used in the electrophysiological experiments using SP6 and T7 polymerase according to standard protocols.
Microinjection. DNA plasmids were diluted to 400 g/ml in calcium-and glucose-free Krebs' solution (290 mOsm/l, pH 7.3) containing 0.5% FITCdextran and pressure-injected into the nucleus of SCG neurons 2 d in culture, either as described previously (Abogadie et al., 1997) or with a microinjector (Eppendorf, Hamburg, Germany). Cells were maintained in culture for an additional 2 d, and a survival rate of 75-85% was obtained.
Electrophysiolog y. M-currents were measured from SCG neurons cultured for 4 d, using the amphotericin-B perforated-patch technique (Horn and Marty, 1988; Rae et al., 1991) . Patch electrodes (2-4 M⍀) were filled by dipping the tip for 40 sec into a filtered internal solution containing (in mM): potassium acetate 80, KC l 30, H EPES 40, MgC l 2 3 (adjusted to pH 7.3-7.4 with KOH and to 280 mOsm / l with potassium acetate). The pipette was then back-filled with the above solution containing 0.1 mg /ml amphotericin-B. High-resistance seals (Ͼ2 G⍀) were initially achieved, and after amphotericin-B permeabilization, access resistances were Ͻ25 M⍀. SCG neurons were perf used at 5-10 ml /min at 32°C with an external solution consisting of (in mM): NaC l 120, KC l 3, H EPES 5, NaHC O 3 23, glucose 11, MgC l 2 1.2, C aC l 2 2.5, tetrodotoxin (TTX) 0.0005, pH 7.4. C ells were voltage-clamped at approximately Ϫ25 mV using either an Axopatch 200A amplifier (data sampling rate 4 -10 kHz, filter 1 kHz) or a switching amplifier (Axoclamp-2A, switching frequencies 3-5 kHz, filter 0.1 kHz), both from Axon instruments (Foster C ity, CA). I K(M) was measured as a slowly developing inward deactivation relaxation after a 1 sec jump to a command potential of approximately Ϫ55 mV (C aulfield et. al., 1994) . Inhibition was measured as the fractional reduction in the amplitude of the I K(M) deactivation relaxation in response to cumulative increases in concentrations of oxotremorine methiodide (Oxo-M) (Research Biochemicals International, Natick, M A) (see Fig. 4 ). Steady-state current-voltage relationships were obtained by applying slow (3.3 mV/sec) voltage ramps from Ϫ20 mV to Ϫ100 mV. For experiments with Bordetella pertussis toxin (P TX) (Speywood, Maidenhead, Berkshire, UK), SCG neurons were incubated with 1 g /ml P TX in the culture medium for at least 24 hr before recording.
Data were collected and analyzed using PC lamp6 software (Axon Instruments) and expressed as mean Ϯ SEM. An estimate of the mean log IC 50 for each antisense plasmid treatment was obtained by fitting the data from each individual cell with a best-fit dose -response curve and determining the log IC 50 for each cell. I K(M) deactivation relaxations were best-fit by a double exponential with fast (1) and slow (2) components. Statistics used the two-way ANOVA comparing plasmid treatments across four agonist concentrations for all antisense samples (in- Figure 1 . DNA Sequences of G␣ q and G␣ 11 3Ј untranslated regions. Sequences of rat G␣ q and G␣ 11 in the 3Ј untranslated region immediately after the stop codon. Homology between the two proteins is very low in this region, with only 19% identity, although this rises to 31% when the two sequences are aligned for maximum homology. The underlined areas represent the sequences targeted by the G␣ 11 antisense plasmids; the closed arrowheads correspond to clone 243-7 and the open arrowheads to clone C97-4.
cluding uninjected groups). If a significant effect of plasmid treatment was found overall, f urther analysis was performed using the two-way ANOVA to determine which treatments contributed to this significance. The constitutively active G␣ oA* , G␣ q* , G␣ 11* , and ␤ 1 ␥ 2 expression data were analyzed with one-way ANOVA, as was the log IC 50 data, and if an overall significant effect of plasmid treatment was found, this was followed by Bonferroni's multiple comparison test. p values Ͻ 0.05 were considered significant.
Immunoc ytochemistr y. SCG cells, cultured and injected as described above, were fixed in acetone and stained for G␣ oAϩB , G␣ q , G␣ 11 , and C terminus of ␤ARK1 using selective antibodies and the alkaline phosphatase substrate 5-bromo-4-chloro-3-indoxyl phosphate and nitro blue tetrazolium chloride (BCI P/ N BT) (Dako, C arpinteria, CA), as described by Abogadie et al., (1997) . The polyclonal antibodies anti-G␣ oAϩB (sc-387), anti-G␣ 11 (sc-394), and anti-␤ARK1 C terminus (sc-562) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and the anti-G␤ antibody (3B-200) was from Gramsch Laboratories (Schwabhausen, Germany). The specific polyclonal antibody anti-G␣ q (IQB2) was raised against a synthetic peptide fragment of G␣ q . Specificity of the antibodies was determined by competing out the staining by preabsorbing the antibody with the relevant immunogenic peptide. All dishes of SCG neurons recorded in the electrophysiology experiments were subsequently fixed and stained. The BCI P/ N BT purple/ blue product was too dark to quantitate photometrically, so we assessed whether there was an overall qualitative reduction in staining by comparing each injected cell with its nearest uninjected neighbor and determining (by eye) whether the level of staining was equal to or less than that of the uninjected cell. Using this method we have therefore estimated the proportion of cells with a visible reduction in staining (regardless of the magnitude of this reduction) 48 hr after injection of the antisense plasmid.
RESULTS

G␣ q and G␣ 11 expression in SCG neurons
Both in situ hybridization and RT-PCR clearly showed the presence of G␣ q and G␣ 11 mRNAs in rat SCG tissue where they were expressed mainly in neurons (Fig. 2) . The specificity of the hybridization probes was confirmed when no signal was seen after competition with unlabeled probes (data not shown) or after use of sense, rather than antisense, probes (Fig. 2) . Staining with specific antibodies against G␣ q and G␣ 11 demonstrated the presence of G␣ q and G␣ 11 protein in most cultured SCG neurons (see below). We have constructed plasmids encoding for RNA antisense (antisense plasmids) directed against the 3Ј untranslated region of these G-proteins to specifically deplete cells of each of the ␣-subunits. G␣ q and G␣ 11 share 81% homology in coding region sequence (based on mouse sequence), and this drops to a maximum of 31% (when rat sequences are aligned for maximum homology) in the first 200 bases of the 3Ј untranslated region in rat (Fig. 1) .
Direct intranuclear injection of SCG neurons with various antisense plasmids (G␣ q , G␣ 11 , and G␣ oA ) resulted in a marked reduction in the respective G␣ subunit staining 48 -72 hr later (Fig. 3) . This protein depletion was specific, with G␣ oA antisense not altering G␣ q or G␣ 11 staining, G␣ q /11 common antisense not touching G␣ oAϩB staining, G␣ q not altering G␣ oAϩB or G␣ 11 staining, and G␣ 11 antisense leaving G␣ oAϩB and G␣ q staining intact. The two G␣ 11 antisense plasmids, however, were not equally effective. Thus, clone C97-4 reduced visible G␣ 11 protein staining in 9 of 19 cells (47%; n ϭ 7 dishes of cells) (see Materials and Methods) (Fig. 3C) , whereas 243-7 reduced G␣ 11 staining in only 18 of 63 cells (29%; n ϭ 17 dishes). Similarly, the specific G␣ q antisense plasmids were not all effective. C6 -6 and C23-24 reduced staining in 23 of 71 cells (32%; n ϭ 8 dishes) and 8 of 32 cells (25%; n ϭ 6 dishes), respectively (Fig. 3B) , whereas C23-D7 and C23-16 were more effective, reducing staining in 31 of 65 cells (48%; n ϭ 10 dishes) and 55 of 109 cells (50%; n ϭ 21 dishes), respectively (Fig. 3B) . The antisense plasmids were maximally effective in reducing G␣ subunit staining 2 d after injection, and their effects on I K(M) modulation were therefore assessed 2 d after injection.
Effect of antisense plasmids on I K(M) modulation by a muscarinic agonist
Injection of DNA plasmids encoding antisense to G␣ oA slightly reduced inhibition of I K(M) by the muscarinic agonist Oxo-M. Thus, the inhibition of I K(M) by 300 nM Oxo-M was 24.6 Ϯ 5.0% (n ϭ 6) in G␣ oA antisense-treated cells compared with 34.2 Ϯ 2.6% (n ϭ 7) in uninjected cells ( p ϭ 0.007 across all Oxo-M concentrations) (see Fig. 5B ). To investigate further this effect of G␣ oA antisense, we pretreated several dishes of SCG neurons with 1 g/ml PTX, which ADP-ribosylates and inactivates members of the G␣ o/i G-protein family. There was no significant difference in Oxo-M inhibition of I K(M) between the treated and untreated cells (see Fig. 5D ), confirming previous findings with other mAChR agonists . A comparable treatment strongly attenuated the G o -mediated inhibition of the Ca 2ϩ current by noradrenaline (Caulfield et al., 1994) and Oxo-M (Delmas et al., 1998b) . Furthermore, overexpression of a constitutively active, GTPase-deficient form of G␣ oA (Wong et al., 1992) did not alter I K(M) density (see Fig. 8 and below). It seems unlikely, therefore, that the G␣ oA antisense-induced reduction in I K(M) inhibition results directly from the loss of G␣ oA or that G␣ oA participates in I K(M) inhibition, a conclusion supported by previous studies using specific antibodies (Caulfield et al., 1994) . This reduction is also unlikely to be caused by the plasmid injection per se, because cells injected with antisense constructs that were ineffective in reducing protein had no effect on the Oxo-M dose-response curves (see Fig. 5B ,C and below). Hence, we do not yet understand why the G␣ oA antisense plasmid reduced I K(M) inhibition. Nevertheless, because the most suitable control group for comparison with the G␣ q and G␣ 11 antisense plasmids is the expression of an inappropriate antisense, we have taken the effect of the G␣ oA antisense as our baseline for assessing the effect of the G␣ q and G␣ 11 antisense plasmids, because at the very least this would mitigate against any "nonspecific" effects of antisense plasmid injection. Thus, all p values quoted are compared against G␣ oA antisense-expressing neurons unless stated otherwise (in practice, the same outcome of the experiments below would be obtained if the comparison were with uninjected cells).
Injection of SCG neurons with the G␣ q /11 common antisense plasmid significantly reduced Oxo-M inhibition of I K(M) when compared with G␣ oA antisense-expressing cells (G␣ oA antisense: 24.6 Ϯ 5.0% inhibition with 300 nM Oxo-M, n ϭ 6; G␣ q /11 antisense: 13.9 Ϯ 2.2%, n ϭ 6; p ϭ 0.005 across all Oxo-M concentrations) (see Fig. 5B ). This confirms previous observations, using functionally inactivating antibodies, that either G␣ q or G␣ 11 or both mediate muscarinic inhibition of I K(M) (Caulfield et al., 1994) . To determine which (or whether both) of these G-protein ␣ subunits is responsible for mediating this response, cells were injected with antisense plasmids that specifically reduced G␣ q and G␣ 11 levels (see above). Four plasmids encoding different G␣ q antisense sequences were investigated (see Fig. 5A ). Of these, two significantly reduced muscarinic inhibition of I K(M) (C23-D7 and C23-16) (percentage inhibition with 300 nM Oxo-M: C23-D7: 15.5 Ϯ 4.7%, n ϭ 6, p ϭ 0.004 compared with G␣ oA dose-response curve; C23-16: 15.7 Ϯ 3.7%, n ϭ 9, p ϭ 0.001) (Figs. 4, 5C ). This is in agreement with the immunocytochemical data where the clones C23-D7 and C23-16 selectively reduced immunocytochemical staining of G␣ q . The other two clones, C6 -6 and C23-24, however, were less effective at reducing either G␣ q staining or muscarinic inhibition of I K(M) (percentage inhibition of I K(M) with 300 nM Oxo-M: C6 -6: 24.3 Ϯ 5.0%, n ϭ 8; C23-24: 24.3 Ϯ 3.0%, n ϭ 5) (Fig. 5C ). The attenuation of I K(M) inhibition by the G␣ q antisense plasmids C23-D7 and C23-16 was reflected in an increase in the log IC 50 for these groups. Although the log IC 50 values for neurons injected with C6 -6 (Ϫ6.14 Ϯ 0.09; n ϭ 8) and C23-24 (Ϫ6.07 Ϯ 0.11; n ϭ 5) were close to that for uninjected neurons (Ϫ6.31 Ϯ 0.06; n ϭ 6), those for SCG neurons injected with the G␣ q antisense plasmids C23-D7 (Ϫ5.64 Ϯ 0.23; n ϭ 6) and C23-16 (Ϫ5.16 Ϯ 0.37; n ϭ 7; p Ͻ 0.05 compared with G␣ 11 antisense-expressing neurons) were greater (Fig. 6) . G␣ q depletion did not significantly change the maximum response or Hill slope. In contrast with the G␣ q antisense plasmids, I K(M) inhibition in cells depleted of G␣ 11 with C97-4 antisense plasmid (29.7 Ϯ 4.1% inhibition at 300 nM Oxo-M; log IC 50 ϭ Ϫ6.13 Ϯ 0.09; n ϭ 9) was no different from that seen in G␣ oA antisenseexpressing neurons (Figs. 4, 5B, 6 ). In agreement with the time course of G␣ subunit depletion, the reduction of Oxo-M inhibition was maximal at 48 hr for the concentration of the plasmid injected (400 g/ml), because no further reduction was seen 72 hr after injection [e.g., at 72 hr, 300 nM Oxo-M produced 17.4 Ϯ Figure 2 . In situ hybridization and RT-PCR demonstrate the presence of G␣ q and G␣ 11 mRNA in rat SCG. In situ hybridization (ISH) and RT-PCR demonstrate the presence of G␣ q and G␣ 11 in rat SCG. ISH of G␣ q ( B) and G␣ 11 ( C) shows neuronal staining. G␣ oA ISH ( A) was used as a positive control. All probes used were against the 3Ј untranslated region (3Ј UTR) of the gene. The black arrows indicate representative individual SCG neurons expressing the relevant mRNA. D, RT-PCR using rat SCG DNA as a template. m, Marker lane; o, G␣ o with primers 266s/849a; q, G␣ q with primers G␣ q u6s/u111a, where "u" denotes sequence in the 3Ј UTR; 11, G␣ 11 with primers G␣ 11 488s/u103a; bp, base pair.
2.7% (n ϭ 9) inhibition of I K(M) in G␣ q antisense (C23-16)-expressing cells)]. The resting membrane potential was not altered in neurons injected with the G␣ q or G␣ 11 antisenses compared with G␣ oA antisense constructs (e.g., G␣ oA antisense: Ϫ63.5 Ϯ 2.6 mV, n ϭ 6; G␣ q antisense, C23-D7: Ϫ63.8 Ϯ 1.1 mV, n ϭ 5; G␣ 11 antisense, C97-4: Ϫ62.0 Ϯ 4.0 mV, n ϭ 4).
Expression of the C-terminal ␤ARK1 peptide in SCG neurons
The above results suggest that G␣ q is primarily responsible for M1 mAChR-induced inhibition of I K(M) , but they do not indicate which subunit(s) of the heterotrimer mediates the inhibition. To determine the role of endogenous G␣ q -linked ␤␥ dimers, we overexpressed the C -terminal domain of ␤ARK1, which has been shown to sequester free ␤␥ subunits (Koch et al., 1994) . E xpression of the peptide was routinely detected 24 -48 hr after injection as a strong increase in ␤ARK1 peptide immunoreactivity. Injection of the ␤ARK1 construct at 200 g /ml, a concentration that has been found to be effective at attenuating noradrenergic inhibition of the calcium current (Delmas et al., 1998a ), a presumed ␤␥-mediated pathway (Herlitze et al., 1996; Ikeda, 1996) , did not alter inhibition of I K(M) (300 nM Oxo-M produced 21.8 Ϯ 3.2% inhibition in ␤ARK1-expressing cells; n ϭ 8) (Fig. 7) . Increasing the plasmid concentration to 400 g /ml, however, resulted in a reduction of M1 mAChR inhibition of I K(M) (300 nM Oxo-M resulted in 17.7 Ϯ 2.4% inhibition, n ϭ 7, p ϭ 0.0002, compared with G␣ oA antisense plasmid cells, across all concentrations of Oxo-M) (Fig. 7) . This effect was not a result of a use-dependent sequestration of ␤␥ subunits by ␤ARK1 peptide, because repetitive application of 1 M Oxo-M did not result in an accumulated loss of inhibition in neurons injected with 400 g /ml ␤ARK1-encoding plasmid (first application, 40.5 Ϯ 4.0% inhibition; fourth application, 37.7 Ϯ 4.1%; n ϭ 3). Furthermore, neither I K(M) current density (G␣ oA anti- C23-D7) . B, C ells immunostained with G␣ q antibody and neurons injected with ( i) G␣ q antisense plasmid (C23-D7), (ii) G␣ oA antisense plasmid, (iii) G␣ q antisense plasmid (C23-24), and (iv) G␣ 11 antisense plasmid (C97-4). C, Cells immunostained with G␣ 11 antibody and neurons injected with ( i) G␣ 11 antisense plasmid (C97-4) and (ii) G␣ q antisense plasmid (C23-D7).
sense: 2.8 Ϯ 0.4 pA /pF, n ϭ 7; 400 g /ml ␤ARK1: 4.7 Ϯ 1.1 pA /pF, n ϭ 7) nor I K(M) deactivation relaxation (G␣ oA antisense: 1 40.3 Ϯ 2.3 msec, 2 263 Ϯ 21 msec, n ϭ 9; 400 g /ml ␤ARK1: 1 37.2 Ϯ 2.2 msec, 2 248 Ϯ 30 msec, n ϭ 10) was significantly altered by the ␤ARK1-encoding plasmid.
Expression of GTPase-deficient forms of G␣ q and G␣ 11 subunits, but not ␤ 1 ␥ 2 dimers, inhibits I K(M)
The above experiments with ␤ARK1 peptide expression suggest that ␣, rather than ␤␥, subunits mediate M1 mAChR inhibition of I K(M) . To test this further, we overexpressed GTPase-deficient, constitutively active forms of G␣ oA (G␣ oA* , Q205L), G␣ q (G␣ q* , Q209L), G␣ 11 (G␣ 11* , Q209L), and ␤ 1 ␥ 2 dimers. Overexpression of G␣ q* and G␣ 11* resulted in a dramatic decrease in I K(M) current density 24 -48 hr after injection, compared with cells injected with G␣ oA antisense plasmid or G␣ oA* (Fig. 8 A,C) (G␣ oA antisense: 2.8 Ϯ 0.4 pA/pF, n ϭ 7; G␣ oA* : 4.0 Ϯ 0.6 pA/pF, n ϭ 6; G␣ q* : 0.2 Ϯ 0.02 pA/pF, n ϭ 13, p Ͻ 0.001, compared with either G␣ oA antisense or G␣ oA* ; G␣ 11* : 0.1 Ϯ 0.02 pA/pF, n ϭ 8, p Ͻ 0.001, compared with either G␣ oA antisense or G␣ oA* ). This loss of I K(M) was also clear in the steady-state current-voltage relationships by the absence of outward rectification positive to Ϫ60 mV in G␣ q* -and G␣ 11* -expressing cells (Fig. 8 B) . Consistent with the suppression of I K(M) , the resting membrane potential of these cells was more depolarized than in cells injected with G␣ oA antisense and G␣ oA* plasmids (G␣ oA antisense: Ϫ63.5 Ϯ 2.6 mV, n ϭ 6; G␣ oA* : Ϫ62.7 Ϯ 0.7 mV, n ϭ 6; G␣ q* : Ϫ48.4 Ϯ 1.7 mV, n ϭ 13, p Ͻ 0.001, compared with either G␣ oA antisense or G␣ oA* ; G␣ 11* : Ϫ50.3 Ϯ 2.7 mV, n ϭ 8, p Ͻ 0.01, compared with G␣ oA antisense or G␣ oA* ). In contrast, overexpression of free ␤␥ subunits, by coexpressing ␤ 1 and ␥ 2 subunits, had no significant effect on either I K(M) current density (2.03 Ϯ 0.4 pA/pF, n ϭ 6; p Ͼ 0.05 compared with G␣ oA antisense) (Fig. 8C) or resting membrane potential (Ϫ59.2 Ϯ 1.8, n ϭ 6; p Ͼ 0.05, compared with G␣ oA antisense).
DISCUSSION
Our data clearly demonstrate that direct intranuclear injection of antisense-generating plasmids is an effective method for reducing levels of G-protein subunits in neurons (Fig. 3) . These antisense sequences, designed against the 3Ј UTR for increased specificity, are thought to bind to their target regions and destabilize the whole mRNA (Phillips and Gyurko, 1997) that not all G␣ 3Ј UTR antisense sequences were effective in reducing protein expression. Of four G␣ q antisense sequences tested, only two were effective (C23-D7 and C23-16). Similarly, of two G␣ 11 antisense sequences tested, only one (C97-4) consistently reduced G␣ 11 protein levels. This difference in effectiveness of the antisense sequences could perhaps arise from some unknown secondary structure in the target mRNA transcript (Phillips and Gyurko, 1997) . Such structures may determine how accessible the target region is for binding by antisense transcripts. The two less effective G␣ q antisenses include a short region between nt 6 and 28 in the 3Ј UTR not covered by the other antisense sequences (Fig. 5) . It is therefore tempting to speculate (bp)] and relative positions of the four antisense sequences targeted at the 3Ј untranslated region of rat G␣ q . Only C23-D7 and C23-16 consistently reduced G␣ q protein levels in immunocytochemical staining with a G␣ q antibody. B, Dose -response curves (mean Ϯ SEM, plus best-fit curve) for uninjected neurons compared with G␣ oA antisense, G␣ 11 antisense, and G␣ q /11 antisense plasmid-injected cells. The dose -response curve for G␣ oA (n ϭ 6) antisense is significantly different from the uninjected dose -response curve (n ϭ 6; p ϭ 0.007) but not the G␣ 11 antisense plasmid curve (n ϭ 9). The dose-response curve for cells injected with the G␣ q /11 common antisense plasmid (n ϭ 6) is significantly different from those of cells injected with G␣ oA and G␣ 11 antisense plasmids ( p ϭ 0.005 and p Ͻ 0.0001, respectively). C, Oxo-M dose -response curves for neurons injected with G␣ 11 antisense plasmid and four different antisense plasmids against G␣ q . The dose -response curves for C6 -6 (n ϭ 8) and C23-24 (n ϭ 5) are not significantly different from the dose -response curves for G␣ oA antisense-expressing ( B) or G␣ 11 antisense-expressing neurons. C23-D7 (n ϭ 6) and C23-16 (n ϭ 9) dose-response curves are both significantly different from G␣ oA antisense-expressing neurons ( p ϭ 0.004 and p ϭ 0.001, respectively) and from G␣ 11 antisense-expressing neurons ( p Ͻ 0.0001 and p Ͻ 0.0001, respectively). D, Oxo-M inhibition of I K(M) is not altered by pretreatment with 1 g/ml PTX (n ϭ 6; n ϭ 4 for untreated neurons). that this particular region or sequence might not be amenable to antisense action.
Using these specific antisense plasmids, we have shown that depletion of G␣ q , but not G␣ 11 , subunits significantly reduced muscarinic inhibition of I K(M) (Figs. 4, 5) . Indeed, although both in situ hybridization and immunocytochemical experiments clearly demonstrated the presence of G␣ 11 in SCG neurons (Figs.  2, 3) , muscarinic inhibition of I K(M) was not altered in cells specifically depleted of G␣ 11 by the antisense plasmid (Figs. 3-6 ). This suggests that G␣ q rather than G␣ 11 preferentially mediates M1 mAChR inhibition of I K(M) . This idea is supported by the finding that the common G␣ q /11 antisense plasmid produced no greater reduction in I K(M) inhibition than the specific G␣ q antisense plasmids. Although G␣ q antisense plasmids clearly shifted the dose-response curve for Oxo-M inhibition of I K(M) , they did not completely prevent inhibition by this mAChR agonist. This partly results from the variable response between neurons expressing the G␣ q antisense: some cells display very little inhibition when Oxo-M is applied, whereas others resemble uninjected neurons and robust inhibitions are observed (Fig. 6 ). This finding mirrors the results obtained when antibodies directed against G␣ q /11 were directly injected into SCG neurons. In these neurons there was an overall reduction in mean inhibition but a wide range of responses, from no reduction to total suppression in individual cells (Caulfield et al., 1994; Brown et al., 1995) . The variability seen with the G␣ q antisense plasmids may most reasonably be attributed to a variable reduction in endogenous G␣ q protein.
Although the participation of additional G-proteins cannot be totally excluded, this seems less likely because one would then have to postulate that the component of inhibition mediated by G q varied greatly from one cell to another in an apparently arbitrary manner. Certainly, if another G-protein is involved, it must be insensitive to PTX (Fig. 5D) , and it cannot be G 11 because (1) G␣ 11 antisense plasmids were unable to alter I K(M) inhibition and (2) the G␣ q /11 common antisense had no more effect than the specific G␣ q antisense plasmids (Figs. 5B,C, 6 ).
The inequality between G␣ q and G␣ 11 function in these cells is somewhat surprising, because the bulk of evidence implies that G␣ q and G␣ 11 are indistinguishable in both receptor-coupling and effector-coupling preference. These studies have been based mainly on purified protein in cell-free systems (Taylor et al., 1991) or cloned wild-type and constitutively active proteins expressed in cell lines (Aragay et al., 1992; Wu et al., 1992a,b; Hepler et al., 1993) . Studies using antisense oligonucleotides, however, have implicated (1) both G␣ q and G␣ 11 in M1 mAChR activation of PLC-␤ in RBL-2H3 cells (Dippel et al., 1996) but( 2) neuromedin B receptor activation of PLC occurring via G␣ q , and not G␣ 11 , in Xenopus oocytes (Shapira et al., 1994) . Furthermore, in both rat myocytes and Xenopus oocytes, endogenous G␣ q and G␣ 11 ap- M) in cells injected with either G␣ oA antisense plasmid (n ϭ 6) or C -terminal ␤ARK1 plasmid at 200 g/ml (n ϭ 8) or 400 g/ml (n ϭ 7) are shown. Only the ␤ARK1 400 g/ml dose -response curve is significantly different from the G␣ oA antisense dose -response curve ( p ϭ 0.0002).
pear to have distinctly different f unctions after thyrotropinreleasing hormone or ␣ 1 -adrenergic receptor activation (Lipinsky et al., 1992; Macrez-Leprêtre et al., 1997) . These studies, and our results, suggest that the coupling preferences suggested by in vitro and overexpression studies may not reflect those found in native cells.
The lack of involvement of G␣ 11 in mediating I K(M) inhibition does not seem to arise from an inability of the subunit to couple to appropriate effector systems, because both G␣ 11* and G␣ q* virtually abolished I K(M) . It is more likely, therefore, that the M1 muscarinic receptor preferentially links to G␣ q , rather than G␣ 11 , in these neurons. Because studies with recombinant G␣ q and G␣ 11 have demonstrated that both of these subunits are capable of coupling to M1 receptors (Nakamura et al., 1995) , differential receptor coupling might arise from a greater abundance of G␣ q relative to G␣ 11 . L ower levels of G␣ 11 , relative to G␣ q , have been observed in most cell lines and all regions of brain examined (Milligan, 1993) , and Western blots from whole ganglia indicate that these proteins may not be equally expressed in SCG (C aulfield et al., 1994) . Alternatively, differences in membrane compartmentalization of G␣ q and G␣ 11 could result in differential access to the receptor, as has been suggested for G␣ i and G␣ o (Neubig, 1994; Gudermann et al., 1996) . Membrane association of G␣ q and G␣ 11 is primarily determined by their N-terminal regions where the palmitoylation sites and the regions essential for ␤␥ subunit interaction are situated Milligan et al., 1995; Hepler et al., 1996) . Because this region also contains the greatest amino acid diversity between G␣ q and G␣ 11 (Strathmann and Simon, 1990) , it is possible that they may differ in their membrane association or distribution. Recent work by Umemori et al. (1997) indicates that G␣ q and G␣ 11 can undergo phosphorylation by tyrosine kinase after M1 mAChR activation and that this is required for activation of the subunits and leads to disassociation of the receptor-G-protein complex. A final possibility, therefore, could be that the phosphorylation states of G␣ q and G␣ 11 in SCGs may differ, thereby altering their ability to interact with the receptor. Nevertheless, the effectiveness with which the GTPaseresistant G␣ 11 inhibits I K(M) leaves open the possibility that G␣ 11 may mediate PTX-insensitive inhibition of I K(M) via other receptors such as angiotensin II (Shapiro et al., 1994) or bradykinin (the effect of which is also inhibited by the G␣ q /11 antibody) .
The strong suppression of I K(M) after overexpression of GTPase-resistant ␣ q (and ␣ 11 ), but not ␣ oA , suggests that inhibition might well be mediated by dissociated GTP-bound ␣ q Figure 8 . Expression of GTPase-deficient forms of G␣ q and G␣ 11 tonically inhibits I K(M) , whereas ␤ 1 ␥ 2 dimers have no effect. A, Representative waveforms from cells in C. Neurons expressing constitutively active G␣ q* or G␣ 11* have very little holding current at Ϫ20 mV and no I K(M) deactivation relaxation in response to a Ϫ30 mV voltage step (bottom trace). I K(M) is normal in cells expressing ␤ 1 ␥ 2 dimers compared with injected neurons (e.g., G␣ oA antisense-expressing cells). Waveforms are the average of three traces, and the dotted line represents 0 pA. B, Current-voltage curves in response to a voltage ramp from Ϫ20 to Ϫ100 mV at 3.3 mV/sec (displayed in insert) in G␣ oA antisense-expressing cells and neurons expressing G␣ q* or G␣ 11* . I-V plot is in reverse direction from the ramp applied, and the dotted line represents 0 pA. These traces have not been leak-subtracted; leak current in the G␣ q* and G␣ 11* cells is less than in the G␣ oA antisense-expressing neurons. C, Scatter-plot of I K(M) densities in G␣ oA antisense-expressing cells and cells expressing G␣ oA* , G␣ q* , G␣ 11* , and ␤ 1 ␥ 2 dimers. Horizontal lines represent means of each group. G␣ q* (n ϭ 13) and G␣ 11* (n ϭ 8) are significantly different from G␣ oA antisense-expressing neurons (n ϭ 7) ( p Ͻ 0.001 and p Ͻ 0.001, respectively), G␣ oA* -expressing neurons (n ϭ 6) ( p Ͻ 0.001 and p Ͻ 0.001, respectively), and ␤ 1 ␥ 2 dimer-expressing neurons (n ϭ 6) ( p Ͻ 0.01 and p Ͻ 0.01, respectively).
subunits but does not, of itself, exclude the possibility that ␤␥ subunits released from the endogenous ␣␤␥ heterotrimer might be the physiological mediator of inhibition. However, this possibility seems unlikely for two reasons. First, co-overexpression of ␤ 1 with ␥ 2 subunits did not significantly reduce I K(M) (Fig. 8) . In parallel experiments, this procedure effectively inhibited the N-type voltage-gated C a 2ϩ current in these neurons (Delmas et al., 1998a) , an inhibitory process considered from previous work to be driven by free ␤␥ subunits (Ikeda, 1996; Herlitze et al., 1996) . Second, muscarinic inhibition of I K(M) was unaffected in neurons injected with 200 g/ml of a construct expressing the C-terminal sequence of ␤ARK1 (also known as GRK2), which binds and sequesters free ␤␥ subunits (Koch et al., 1994) (Fig. 7) . Again, in parallel experiments, this concentration of the ␤ARK1 construct reduced I C a inhibition by noradrenaline and Oxo-M (Delmas et al., 1998a,b) . Although increasing the plasmid concentration (to 400 g/ml) did attenuate I K(M) , this might be a nonspecific effect. We cannot exclude the possibility that the ␤␥ dimer associated with G␣ q might have a low affinity for the ␤ARK1 ␤␥-binding domain [for instance, ␤ 3 subunits cannot interact with ␤ARK1 (Daaka et al., 1997) ]. However, G␣ q and G␣ 11 can form heterotrimers with ␤ 1 ␥ 2 dimers (Nakamura et al., 1995) , and ␤ARK1 abolishes muscarinic-activated calcium release in Xenopus oocytes, a response involving both G␣ q and G␣ 11 (Stehno-Bittel et al., 1995) .
Hence, and in conclusion, our results suggest that the pathway involved in muscarinic inhibition of I K(M) in rat SCG neurons requires G␣ q but not G␣ 11 and that it is the ␣ subunit of the heterotrimer G q , rather than the ␤␥ dimer, that acts as the primary transducer. To this extent, they also provide further evidence that coupling between receptors and G-proteins in neurons is highly specific and more subtle than experiments with reconstituted subunits might indicate.
